Green Thumb Industries (GTBIF) Operating Margin (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Operating Margin came in at 13.57% in Q1 2026, down 163.0% YoY from 21.54% in Q1 2025, and up 121.69% on a QoQ basis from 6.12% in Q4 2025.
Green Thumb Industries (GTBIF) Operating Margin (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Operating Margin data on file, last reported at 13.57% in Q1 2026.
- Quarterly Operating Margin fell 163.0% year-over-year to 13.57% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.37% (down 583.0% YoY) and the FY2025 annual result came in at 11.72%, down 802.0% from the prior year.
- Operating Margin grew to 13.57% in Q1 2026, from 6.12% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 25.62% in Q1 2024 to a low of 17.17% in Q4 2022.
- A 5-year average of 15.21% and a median of 17.78% in 2023 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2022 — Operating Margin slumped 3950 bps — and 2023, when it surged 3526 bps.
- Tracing GTBIF's Operating Margin over 5 years: stood at 17.17% in 2022, then soared by 205 bps to 18.09% in 2023, then rose by 7 bps to 19.4% in 2024, then tumbled by 68 bps to 6.12% in 2025, then jumped by 122 bps to 13.57% in 2026.
- The last three Operating Margin figures came in at 13.57% (Q1 2026), 6.12% (Q4 2025), and 12.61% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 6.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.51% |
| Mar 31, 2026 | 13.57% |
| Dec 31, 2025 | 6.12% |
| Sep 30, 2025 | 12.61% |
| Jun 30, 2025 | 13.45% |
| Mar 31, 2025 | 15.20% |
| Dec 31, 2024 | 19.40% |
| Sep 30, 2024 | 14.86% |
| Jun 30, 2024 | 19.28% |
| Mar 31, 2024 | 25.62% |
| Dec 31, 2023 | 18.09% |
| Sep 30, 2023 | 17.80% |
| Jun 30, 2023 | 16.27% |
| Mar 31, 2023 | 17.78% |
| Dec 31, 2022 | -17.17% |
| Sep 30, 2022 | 18.67% |
| Jun 30, 2022 | 24.48% |
| Mar 31, 2022 | 22.49% |
| Dec 31, 2021 | 22.33% |
| Sep 30, 2021 | 24.85% |